Reply: Biological Plausibility Behind the Benefits of Intravenous Metoprolol in Severe COVID-19.

Subjects

Subjects :

Administration, Intravenous
Adrenergic beta-1 Receptor Antagonists
Humans
SARS-CoV-2
COVID-19
Metoprolol

Details

Language :

English

ISSN :

1558-3597

Volume :

79

Issue :

1

Database :

MEDLINE

Journal :

Journal of the American College of Cardiology

Publication Type :

Editorial & Opinion

Accession number :

34991793

Full Text :

https://doi.org/10.1016/j.jacc.2021.10.030